PubRank

A Lindblom

Author PubWeight™ 101.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994 8.04
2 BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 2004 2.75
3 Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 1997 1.88
4 Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A 2001 1.80
5 A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chromosomes Cancer 1998 1.79
6 COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer 2009 1.62
7 Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant 2010 1.59
8 Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms. Mol Biol Cell 1994 1.56
9 Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer 1999 1.44
10 Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 2009 1.38
11 Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut 2002 1.38
12 Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer 1999 1.36
13 Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 2001 1.36
14 High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer 1995 1.34
15 Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physiol 2001 1.32
16 Association studies on 11 published colorectal cancer risk loci. Br J Cancer 2010 1.31
17 A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 1998 1.30
18 Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia 2013 1.27
19 The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res 2001 1.20
20 Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest 2001 1.19
21 Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet 2006 1.18
22 Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res 1995 1.17
23 Anticholinergic medication in diagnostic endoscopy of the upper gastrointestinal tract. Endoscopy 1991 1.16
24 Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006 1.16
25 Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. Genet Test 1999 1.14
26 The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res 1998 1.14
27 The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer 2001 1.13
28 Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res 1998 1.12
29 A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer 2010 1.11
30 Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics. Haemophilia 2013 1.11
31 A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. J Med Genet 2008 1.11
32 COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer 2001 1.10
33 A study of the PTEN/MMAC1 gene in 136 breast cancer families. Hum Genet 1998 1.10
34 High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer. J Med Genet 2005 1.10
35 Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. Genet Test 2005 1.10
36 ATM mutations in cancer families. Cancer Res 1996 1.09
37 Oral sedation for diagnostic upper endoscopy. Endoscopy 1991 1.08
38 MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. Cancer Res 2001 1.06
39 Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet 1997 1.06
40 Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut 2003 1.06
41 Virtual reality colonoscopy simulation: a compulsory practice for the future colonoscopist? Endoscopy 2005 1.05
42 A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med 2001 1.04
43 Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer 2000 1.04
44 Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res 2001 1.04
45 Classification of colorectal polyps: guidelines for the endoscopist. Endoscopy 2002 1.03
46 Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet 2004 1.03
47 Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Int J Cancer 2000 1.01
48 A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer. Gut 2005 1.01
49 Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction. Mutat Res 1998 1.00
50 Ki-ras mutations and prognosis in colorectal cancer. Eur J Cancer 1998 0.99
51 Hereditary breast cancer: a review. Semin Cancer Biol 2000 0.99
52 Missense mutations in hMLH1 associated with colorectal cancer. Hum Genet 1999 0.97
53 FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer 2014 0.96
54 Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspects of surveillance by means of regular colonoscopies. J Clin Oncol 2004 0.95
55 Calcium binding to tandem repeats of EGF-like modules. Expression and characterization of the EGF-like modules of human Notch-1 implicated in receptor-ligand interactions. Protein Sci 1997 0.91
56 Germline mutation screening of the STK11/LKB1 gene in familial breast cancer with LOH on 19p. Clin Genet 2000 0.90
57 TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Br J Cancer 2009 0.90
58 TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer. Br J Cancer 2007 0.90
59 Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients. J Clin Virol 2008 0.89
60 A human compound heterozygote for two MLH1 missense mutations. Nat Genet 1997 0.87
61 Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden. Euro Surveill 2013 0.87
62 Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours. Br J Cancer 1999 0.87
63 Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization. Chromosome Res 1996 0.85
64 BRCA2 germline mutations in Swedish breast cancer families. Eur J Hum Genet 1998 0.84
65 Cytokine responses in acute and persistent human parvovirus B19 infection. Clin Exp Immunol 2007 0.83
66 First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. Genet Test 2001 0.83
67 Preoperative psychological reactions and quality of life among women with an increased risk of breast cancer who are considering a prophylactic mastectomy. Eur J Cancer 2004 0.83
68 Successful management of a planned pregnancy in severe congenital thrombotic thrombocytopaenic purpura: the Upshaw-Schulman syndrome. Transfus Med 2011 0.82
69 Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon. Anticancer Res 1992 0.82
70 Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. Int J Oncol 1998 0.82
71 Improved tumor staging in colorectal cancer. N Engl J Med 1998 0.82
72 A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res 1997 0.82
73 A randomized, double-blind, placebo-controlled study to evaluate topical anaesthesia of the pharynx in upper gastrointestinal endoscopy. Endoscopy 1992 0.82
74 BRCA1 screening in patients with a family history of breast or ovarian cancer. Genet Test 1999 0.81
75 DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with colorectal cancer. Clin Genet 1998 0.81
76 Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Br J Cancer 2011 0.81
77 APC I1307K and E1317Q variants are rare or do not occur in Swedish colorectal cancer patients. Eur J Cancer 2001 0.81
78 Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. Scand J Infect Dis 2001 0.80
79 Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families. Br J Cancer 1997 0.80
80 Sequence variability of a prolonged tetranucleotide repeat. Hum Mol Genet 1995 0.80
81 MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer susceptibility. Eur J Cancer 1998 0.78
82 Laminin isoforms promote attachment of hepatocytes via different integrins. Exp Cell Res 1994 0.78
83 Histological changes pertinent to local tumor progression in hereditary nonpolyposis colorectal cancer (HNPCC). A preliminary report. Anticancer Res 2004 0.78
84 Patient attitudes to sedation for diagnostic upper endoscopy. Scand J Gastroenterol 1991 0.78
85 Low frequency of hMSH2 mutations in Swedish HNPCC families. Int J Cancer 1997 0.78
86 Mutation analysis of the DBC2 gene in sporadic and familial breast cancer. Acta Oncol 2007 0.78
87 Genetic rearrangements in sporadic and familial gastric carcinomas detected with microsatellite markers. Eur J Surg Oncol 1994 0.77
88 The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer. Cancer Res 1998 0.77
89 Mechanism of diarrhea in collagenous colitis. Gastroenterology 2003 0.75
90 Sublocalization of a locus at 3p21.3-23 predisposing to hereditary nonpolyposis colon cancer. Hum Genet 1994 0.75
91 Human parvovirus B19 in pediatric and adult recipients of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2013 0.75
92 Loss of heterozygosity studies in tumors from families with breast-ovarian cancer syndrome. Hum Genet 1994 0.75
93 The use of intragenic polymorphisms in determination of the genomic relevance of whole-exon deletions in MLH1 and MSH2. Clin Genet 2001 0.75
94 [The first breast cancer gene isolated. Safer risk assessment for affected families]. Lakartidningen 1995 0.75
95 [Administering successful periodontal anesthesia]. Tandlakartidningen 1982 0.75
96 Autoimmune markers in lymphoid malignancies. Scand J Immunol 2008 0.75
97 Inhibition of thrombin uptake in fresh human umbilical veins--the effect of protamine concentration. Vasa 1987 0.75
98 Finnish mutations in Swedish HNPCC families. Nat Med 1995 0.75
99 [Nitrous oxide is superior to other anesthetics in colonoscopy]. Lakartidningen 1996 0.75
100 Screening of 229 family cancer patients for a germline estrogen receptor gene (ESR) base mutation. Hum Mutat 1997 0.75
101 Interferon treatment in patients with malignant carcinoids. Acta Oncol 1989 0.75
102 Screening families with endometrial and colorectal cancers for germline mutations. J Med Genet 2001 0.75
103 Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon. Anticancer Res 1992 0.75
104 Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism. J Mol Med (Berl) 2000 0.75